November 17, 2022
A New York federal bankruptcy judge granted Endo International opioid claimants' bid to retain Akin Gump Strauss Hauer & Feld LLP attorneys in ongoing Chapter 11 proceedings, finding that U.S. Trustee's Office objections have been resolved, according to a filing entered Thursday.
November 04, 2022
The U.S. Trustee's Office objected to Endo International opioid claimants' retention of Akin Gump Strauss Hauer & Feld LLP attorneys in ongoing Chapter 11 proceedings Thursday, arguing that the firm represents a party with conflicting interests in the dispute.
October 21, 2022
Navient Solutions is appealing a nationwide injunction barring it from collecting on certain student loans discharged through bankruptcy, Mallinckrodt creditors are suing for the return of $1.6 billion used to buy back shares pre-bankruptcy, and liquidators for crypto hedge fund Three Arrows Capital want to serve subpoenas via Twitter. This is the week in bankruptcy.
October 19, 2022
A New York bankruptcy judge Wednesday gave Endo International approval to use the cash securing its loans after hearing it had made changes to the order in response to creditor complaints that the arrangement was too favorable to secured lenders.
October 07, 2022
Unsecured creditors and opioid claimants in Endo International's Chapter 11 case are asking a New York bankruptcy judge to reject the pharmaceutical maker's request to use cash collateral, saying the proposal gives too much away to secured lenders.
September 28, 2022
A committee representing individual opioid plaintiffs Wednesday told a New York bankruptcy judge they will be pushing for a larger share of the $450 million opioid settlement proposed for pharmaceutical maker Endo International's Chapter 11 plan.
September 15, 2022
The Boy Scouts of America obtained approval for its Chapter 11 plan, the world's second-largest movie theater chain hit bankruptcy, and an examiner was appointed in the Celsius Network cryptocurrency case to investigate management's prepetition conduct. This is the week in bankruptcy.
September 14, 2022
The U.S. Trustee's Office is asking a New York bankruptcy judge to reject Endo Pharmaceuticals' request to make bonus payments to its employees, saying the opioid maker has failed to justify the more than $71 million in payments.
September 12, 2022
Endo Pharmaceuticals is asking a New York bankruptcy judge to pause thousands of state and local government suits against the company over its opioid sales, saying it needs breathing room to finish its Chapter 11 reorganization.
August 22, 2022
An Endo International affiliate Monday asked a New York bankruptcy judge to prevent another pharmaceutical company from canceling pre-Chapter 11 asset purchase and drug licensing deals, denying that it breached the contracts.